| Identifier |
20010222_nanos_neuroimagingsympos_03 |
| Title |
CHAMPS (the Controlled High Risk Avonex Multiple Sclerosis trial) Update |
| Creator |
Steven L. Galetta, MD |
| Affiliation |
NYU Langone |
| Subject |
Optic Neuritis Treatment Trial; Optic Neuritis; Multiple Sclerosis; Controlled High Risk Avonex Multiple Sclerosis Study; Controlled High Risk Avonex Multiple Sclerosis Prevention Surveillance |
| Description |
The optic neuritis treatment trial (ONTI) confirmed the strong association between optic neuritis and multiple sclerosis by identifying those at highest risk for the development of recurrent demyelinating events. For instance, those patients with three or more white matter lesions had a 51% chance of developing multiple sclerosis over the subsequent five years.3 In contrast, those with normal MR scans only had a 16% chance of developing clinically definite MS over the same time period. |
| Date |
2001-02-21 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2001 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
| Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
| Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
| Rights Management |
Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s680885k |
| Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
| Setname |
ehsl_novel_nam |
| ID |
182171 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s680885k |
